Podcasts about ashp

In this podcast, Dr. Megan Rech and Dr. Brett Faine discuss the AJHP theme issue on emergency medicine pharmacy practice with host and AJHP Editor in Chief Dr. Daniel Cobaugh. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

A highlight from exceptional sessions at the 2025 Midyear Clinical Meeting & Exhibition, this episode explores key points for establishing and adjusting anticoagulation management plans for complex patients. The episode discusses key considerations for anticoagulation management in multiple care settings, including ambulatory care and critical care.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

A highlight from exceptional sessions at the 2025 Midyear Clinical Meeting & Exhibition, this episode debates the real clinical differences between ceftriaxone and cefazolin for MSSA infections. They challenge common assumptions, break down the latest evidence, and deliver practical pearls every clinician can use tomorrow. Tune in for sharp insights, spirited discussion, and a verdict that might just change your practice. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This episode explores the concept of psychological safety, which relates to how comfortable we feel taking risks as part of a team. In healthcare, psychological safety can have a tremendous impact on how we care for ourselves, our teammates, and our patients. Our goal is to help folks better understand how they can foster psychological safety in their daily practices.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

The episode will discuss advanced trauma life support with the focus on medication management and the pharmacists' role. Pharmacists can identify other medication related and have an active role in the care of trauma patients. CE for this episode expires 2 years after the date it was originally published.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This episode dives into the ASHP Guidelines on the Evaluation of Off-Label Medication Use in the Inpatient Setting. Off-label prescribing is a common yet complex practice in hospitals, requiring careful oversight to ensure safety, efficacy, and cost-effectiveness. We'll explore the pharmacist's role in this process, the importance of institutional policies, and how Pharmacy and Therapeutics (P&T) Committees can support appropriate use. Whether you're a pharmacy leader, clinician, or health-system administrator, this conversation offers practical insights for navigating off-label use with confidence and clarity. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

A highlight from exceptional sessions at the 2025 Midyear Clinical Meeting & Exhibition, this episode explores how pharmacists can bridge gaps in care for patients with opioid use disorder (OUD), highlighting strategies for prescribing and optimizing medications for OUD across primary, ambulatory, and acute care settings. We will discuss real-world examples, emerging practices like microdosing and direct-to-inject techniques, and ways pharmacists can make a tangible difference in improving patient outcomes. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Një podcast për shëndetin, ndryshe nga të tjerët! “Shëndet me Almën” sjell për ju informacion të saktë, me gjuhë të thjeshtë për shëndetin dhe mirëqenien. Çdo të hënë, gazetarja Alma Demiraj me një karrierë të gjatë në fushën e shëndetësisë, do të diskutojë me mjekë profesionistë shqiptarë dhe të huaj tema që na prekin në jetën e përditshme; që nga zemra te diabeti, nga ushqyerja te shëndeti mendor. Informimi i saktë është hapi i parë për një jetë të shëndetshme.

Pharmacists can be essential in managing myasthenia gravis by providing education, identifying exacerbating medications, offering therapeutic alternatives, and supporting overall appropriate pharmacotherapy. This podcast provides pharmacists with an understanding of the pathophysiology of myasthenia gravis and myasthenic crisis, common complications associated with the disease state, and useful medication management considerations for the emergency department setting. CE for this episode expires on December 20, 2027.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Discover the essential contributions of pharmacists in patient care with We're Your Pharmacist, a monthly podcast from ASHP. This episode features Jennifer Slaughter, ambulatory pharmacy supervisor at SSM Health Dean Medical Group, and her patient Debbie. Jennifer shares what inspired her to pursue a career in pharmacy and discusses the many paths within the profession, while Debbie offers her perspective as a patient and shares insights on the value of the pharmacist–patient relationship.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

A highlight from exceptional sessions at the 2025 Midyear Clinical Meeting & Exhibition, this episode discusses how pharmacists can leverage data, design optimized workflows, and demonstrate financial impact to lead population health initiatives in value-based care models. Listeners will gain practical tools for translating dashboards into interventions, building scalable workflows, and quantifying return on investment to support FTE justification and contract alignment. This conversation offers real-world examples and takeaways to help pharmacists position themselves as indispensable players in team-based care. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

A highlight from exceptional sessions at the 2025 Midyear Clinical Meeting & Exhibition, this episode describes the importance of preparation and professionalism throughout the interview process. Listeners can expect to learn tips and tricks for preparing for residency interviews.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Melanie Dodd, PharmD, PhC, BCPS, FASHP, is the current President of the American Society of Health-System Pharmacists (ASHP) and the Associate Dean for Clinical Affairs and Professor at the University of New Mexico College of Pharmacy. Dr. Dodd talks through her priorities for ASHP this year, her involvement in the progressive New Mexico Society of Health-System Pharmacists, and her advice to those looking to get involved!

Join us for a special podcast series spotlighting student member experiences at 2025 Midyear Clinical Meeting & Exhibition in Las Vegas, NV. Hear perspectives from attendees as they seize opportunities to network, learn and attend residency showcase and PPS. Hear firsthand why Midyear is the place to be – there is nothing like it! The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

A highlight from Exceptional Sessions at the 2025 Midyear Clinical Meeting & Exhibition, this episode discusses agencies and organizations other than USP that impact how we handle Compounded Sterile Preparations. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this podcast, Dr. Anna Dopp and Mr. Tom Kraus discuss the AJHP Editorial "An advocacy roadmap to recognition and payment for pharmacist patient-care services” with host and AJHP Editor in Chief Dr. Daniel Cobaugh. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Anaphylaxis is an acute, life-threatening allergic reaction with an estimated prevalence of approximately 2% in the United States. Prompt recognition of anaphylaxis is necessary for appropriate treatment. This episode will review pathophysiology, clinical presentation and management of anaphylaxis. CE for this episode expires on December 13, 2027.   The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Join us for a special podcast series spotlighting student member experiences at 2025 Midyear Clinical Meeting & Exhibition in Las Vegas, NV. Hear perspectives from attendees as they seize opportunities to network, learn and attend residency showcase and PPS. Hear firsthand why Midyear is the place to be – there is nothing like it!    The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Join us for a special podcast series spotlighting student member experiences at 2025 Midyear Clinical Meeting & Exhibition in Las Vegas, NV. Hear perspectives from attendees as they seize opportunities to network, learn and attend residency showcase and PPS. Hear firsthand why Midyear is the place to be – there is nothing like it! The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

326. BPS Announces Pharmacy Informatics as New Specialty Certification **Intended Audience: Everyone** Today's episode is a very short episode to let you know that the BPS has announced Pharmacy Informatics as a new specialty certification. They are calling on volunteers to serve on the council as the next step. More details here: https://bpsweb.org/2025/12/08/bps-announces-pharmacy-informatics-as-new-specialty-certification/ Disclaimer: Views expressed are those of the individuals and do not reflect thoughts and opinions of any entity with which speakers have been, is now, or will be affiliated. New to LinkedIn and not sure where to start? Download my free ebook, "Professional Networking Unlocked", at https://www.tonydaopharmd.com/#ebook Follow us on social media! Twitter: @pharmacyitme Instagram: @pharmacyinformatics LinkedIn: https://www.linkedin.com/company/pharmacyitme/ Website: Pharmacy IT & Me Email: tony@pharmacyitme.com Follow Tony's personal Twitter account at @tonydaopharmd Network with other pharmacists at Pharmacists Connect!http://pharmacistsconnect.com For more information on pharmacy informatics, check out some of the following useful links: ASHP's Section of Pharmacy Informatics and Technology: https://www.ashp.org/Pharmacy-Informaticist/Section-of-Pharmacy-Informatics-and-Technology/ HIMSS: https://www.himss.org/resources/pharmacy-informatics-and-its-cross-functional-role-healthcare Disclaimer: Views expressed are my own and do not reflect thoughts and opinions of any entity with which I have been, am now, or will be affiliated.

Pain relief medications like acetaminophen and ibuprofen are staples in everyday care—but emerging research suggests they may play a role in antibiotic resistance. This episode reviews recent findings, explores how these common drugs may influence bacterial response to antibiotics, and highlights pharmacist‑specific considerations. You will walk away with practical insights to support informed medication use and strengthen antibiotic stewardship.HOSTRachel Maynard, PharmDGameChangers Podcast Host and Clinical Editor, CEimpactLead Editor, PyrlsGUESTHunter O. Rondeau, PharmD, BCIDP, AAHIVPAntimicrobial Stewardship Coordinator, SSM HealthAdjunct Clinical Assistant Professor, University of Kansas School of PharmacyRachel Maynard has no relevant financial relationships with ineligible companies to disclose. Hunter Rondeau is a consultant for Pyrls, a speaker for ASHP, and was a speaker for ACCP (ended October 2025) and Vituity (ended May 2025). All relevant financial relationships have been mitigated.Pharmacists, REDEEM YOUR CPE HERE!CPE is available to Health Mart franchise members onlyTo learn more about Health Mart, click here: https://join.healthmart.com/CPE INFORMATION Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Describe emerging evidence on how common OTC pain medications may influence antibiotic resistance.2. Identify pharmacist strategies to optimize analgesic and antibiotic use while supporting antimicrobial stewardship.0.05 CEU/0.5 HrUAN: 0107-0000-25-372-H01-PInitial release date: 12/8/2025Expiration date: 12/8/2026Additional CPE details can be found here.

Pain relief medications like acetaminophen and ibuprofen are staples in everyday care—but emerging research suggests they may play a role in antibiotic resistance. This episode reviews recent findings, explores how these common drugs may influence bacterial response to antibiotics, and highlights pharmacist‑specific considerations. You will walk away with practical insights to support informed medication use and strengthen antibiotic stewardship.HOSTRachel Maynard, PharmDGameChangers Podcast Host and Clinical Editor, CEimpactLead Editor, PyrlsHunter O. Rondeau, PharmD, BCIDP, AAHIVPAntimicrobial Stewardship Coordinator, SSM HealthAdjunct Clinical Assistant Professor, University of Kansas School of PharmacyRachel Maynard has no relevant financial relationships with ineligible companies to disclose. Hunter Rondeau is a consultant for Pyrls, a speaker for ASHP, and was a speaker for ACCP (ended October 2025) and Vituity (ended May 2025). All relevant financial relationships have been mitigated. CPE REDEMPTIONThis course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation:If you are already enrolled in this course, click here to redeem your credit. To purchase this episode and claim your CPE credit, click here.CPE INFORMATIONLearning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Describe emerging evidence on how common OTC pain medications may influence antibiotic resistance.2. Identify pharmacist strategies to optimize analgesic and antibiotic use while supporting antimicrobial stewardship.0.05 CEU/0.5 HrUAN: 0107-0000-25-372-H01-PInitial release date: 12/8/2025Expiration date: 12/8/2026Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram

Unhealthy substance use and substance use disorders remain major public health challenges in the United States. As evidence supporting medications for opioid use disorder continues to grow, pharmacists are playing an increasingly important role in managing substance use disorders, particularly by bridging primary care gaps in rural communities and healthcare deserts. This podcast explores how pharmacists are expanding access to care, leveraging telemedicine, collaborating across healthcare teams, and improving public health outcomes. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This episode discusses the current guidelines for the treatment of adult cardiopulmonary arrest, reviews evidence-based algorithms aimed at improving outcomes of survival and discusses the role of pharmacologic therapies recommended for pulseless rhythms.  CE for this episode expires on November 29, 2027.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Join ASHP President, Melanie Dodd, and Vice President of Accreditation Services, Sam Calabrese, as they walk through ASHP's newly updated strategic plan. Speakers share the story behind the plan's development, including how member feedback played a pivotal role in shaping its direction to reflect the needs and aspirations of the pharmacy profession. Speakers highlight the five strategic pillars that form the foundation of the plan and discuss how ASHP is already putting these priorities into action.   The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Discover the essential contributions of pharmacists in patient care with We're Your Pharmacist, a monthly podcast from ASHP. This episode features a panel of pharmacists across a variety of practice areas across the country. They share what inspired them to pursue a career in pharmacy and offers insights into the many paths within the profession, highlighting how pharmacists make a difference every day.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Pharmacists play a critical role in infectious disease care, and staying up to date on antibiotic therapies is key to ensuring optimal patient outcomes. This episode reviews recently FDA-approved antibiotics, offers a practical refresher on commonly used antibiotic classes, and highlights frequent side effects—along with strategies for managing them in practice. Tune in to strengthen your clinical knowledge and support safe, effective antibiotic use across care settings.HOSTJoshua Davis Kinsey, PharmDVP, EducationCEimpactGUESTHunter Rondeau, PharmD, BCIDP, AAHIVPAntimicrobial Stewardship CoordinatorSSM HealthJoshua Davis Kinsey has no relevant financial relationships with ineligible companies to disclose. Hunter Rondeau is a consultant for Pyrls, a speaker for ASHP, and was a speaker for ACCP (ended October 2025) and Vituity (ended May 2025). All relevant financial relationships have been mitigated.  Pharmacists, REDEEM YOUR CPE HERE!CPE is available to Health Mart franchise members onlyTo learn more about Health Mart, click here: https://join.healthmart.com/CPE INFORMATION Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Identify newly FDA-approved antibiotics and their clinical indications.2. Describe commonly used antibiotic classes, their typical side effects, and strategies to manage or mitigate those effects.0.05 CEU/0.5 HrUAN: 0107-0000-25-362-H01-PInitial release date: 11/24/2025Expiration date: 11/24/2026Additional CPE details can be found here.

Pharmacists play a critical role in infectious disease care, and staying up to date on antibiotic therapies is key to ensuring optimal patient outcomes. This episode reviews recently FDA-approved antibiotics, offers a practical refresher on commonly used antibiotic classes, and highlights frequent side effects—along with strategies for managing them in practice. Tune in to strengthen your clinical knowledge and support safe, effective antibiotic use across care settings. HOSTJoshua Davis Kinsey, PharmDVP, EducationCEimpactGUESTHunter Rondeau, PharmD, BCIDP, AAHIVPAntimicrobial Stewardship CoordinatorSSM HealthJoshua Davis Kinsey has no relevant financial relationships with ineligible companies to disclose. Hunter Rondeau is a consultant for Pyrls, a speaker for ASHP, and was a speaker for ACCP (ended October 2025) and Vituity (ended May 2025). All relevant financial relationships have been mitigated.   CPE REDEMPTIONThis course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation:If you are already enrolled in this course, click here to redeem your credit. To purchase this episode and claim your CPE credit, click here. CPE INFORMATIONLearning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Identify newly FDA-approved antibiotics and their clinical indications.2. Describe commonly used antibiotic classes, their typical side effects, and strategies to manage or mitigate those effects.0.05 CEU/0.5 HrUAN: 0107-0000-25-362-H01-PInitial release date: 11/24/2025Expiration date: 11/24/2026Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram

The Centers for Disease Control and Prevention recently released its Core Elements of Hospital Diagnostic Excellence. Given the significant implications of diagnostic stewardship on the use of antimicrobials, US Antibiotic Awareness Week is an excellent opportunity to begin to unpack this topic. This podcast reviews the core elements and explores the opportunities for pharmacists to engage in diagnostic stewardship and how this topic has broader implications beyond antimicrobial use.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Spark Brilliance is the theme for the 2025 ASHP Midyear Clinical Meeting & Exhibition and there's no better place to ignite your clinical pharmacy leadership journey. Join experienced conference attendees and featured speakers as they share insights on leadership, clinical innovation, and professional growth while highlighting everything Midyear has to offer! The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

ASHP's senior education director, Cindy Von Heeringen is joined by William Dager, pharmacist specialist (Ret.) at University of California, Davis Medical Center, as he discusses his upcoming Midyear session that focuses on anticoagulation management plans in complex patients. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This episode guides pharmacists through the essentials of pediatric primary and secondary survey assessment, common etiologies of pediatric cardiopulmonary arrest, pediatric advanced life support algorithms for dysrythmias, and provide useful medication tips and management considerations for the clinical pharmacist. CE for this episode expires on November 15, 2027.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This episode explores why ASHP's Council on Public Policy has taken a fresh approach to a longstanding question: how should pharmacists be reimbursed for cognitive services? Joining the conversation are the council's secretary and a former member who is also a health-system leader. They break down the newly adopted Policy 2506, Payment Parity for Pharmacists' Services, discuss what it aims to accomplish for practicing pharmacists, and examine the broader implications if progress is achieved. The episode unpacks why policy language matters, traces the evolution of ASHP's stance on pharmacist payment parity, and explores how the new policy could help advance this critical issue. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In celebration of Veterans Day, this episode highlights three ASHP members who volunteered to join the military in service to our Nation. Lieutenant Colonel Sherry Kwon, U.S. Army speaks with Navy veteran Tim Lynch, Air Force veteran Nancy Nystrom, and Army veteran Dale English about their stories, reflections, and perspectives on how their military experience helped shape their careers, lives, and their sense of paying it forward to provide an inspiration for others.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast will provide members with an update on federal and state action over the past 6 months on the 340B program. We'll talk through 340B policy shifts at the federal level and what's happening in the states. We'll also discuss where 340B advocacy goes from here.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Ever wondered how pharmacy technicians can shape the future of pharmacy regulation? Listen as pharmacy technicians share their experiences serving on State Boards of Pharmacy and learn how you can advocate for technician representation in your state.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

ASHP's Education Director, Hannah Post, is joined by Kristin Zimmerman, Associate Professor at Virginia Commonwealth University Health, to discuss an upcoming Midyear session presented by Marina Trefethen, PharmD, BCPP, Mental Health Clinical Pharmacist Practitioner at the White River Junction Department of Veterans Affairs Healthcare System. The session explores GLP-1 receptor agonist effects on substance use and addictive behaviors in both clinical trials and real-world populations. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

ASHP co-hosted an invitational summit with APhA and NABP in June 2025 to discuss workplace and well-being issues in the pharmacy workforce. In this episode, two attendees reflect on the experience and the actions of their organizations to improve the pharmacy workplace and discuss the newly released report on the 2025 Implementing Solutions summit. Learn about the new workforce summit report and actionable solutions for well-being that can implemented within an organization. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This episode discusses the evolving standards of care in providing support after rapid sequence intubation (RSI) and highlights RSI pharmacology and the management of post-intubation analgesia and sedation. CE for this episode expires on November 1, 2027.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Discover the essential contributions of pharmacists in patient care with We're Your Pharmacist, a monthly podcast from ASHP. This episode features Amber Lanae Martirosov, associate clinical professor of pharmacy practice at Wayne State University and clinical specialist at Henry Ford Hospital. She shares what inspired her to pursue a career in pharmacy and offers insights into the many paths within the profession, highlighting how pharmacists make a difference every day.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this episode, student leaders from Rutgers University share how their SSHP developed the NxtGen Student Leadership Program—a peer-led initiative focused on building leadership skills and preparing future pharmacy leaders. Listeners will hear how the program was designed, how it engages members at all levels, and the impact it's had on their chapter. This episode offers practical takeaways for other SSHPs interested in starting or strengthening their own leadership development programs.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this episode, current and past executive committee members for the Section of Specialty Pharmacy Practitioners sit down together to share stories and discuss the impact made by the 2024 Distinguished Service Awardee, Tara Kelley.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Join members of the Council on Pharmacy Practice to unpack ASHP's newly approved policy on moral distress and moral injury. They'll explain what these terms mean, share real-world examples, and explore how moral injury contributes to occupational burnout in the pharmacy workforce. The conversation takes you behind the scenes of the policy process, highlighting challenges faced along the way, and look ahead to what this policy means for the future of pharmacy practice. Listeners will be introduced to the emerging concepts of moral distress and moral injury and discover how they impact the pharmacy profession. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

ASHP's education director, Hannah Post, is joined by Curtis Geier, emergency medicine clinical pharmacist at San Francisco General Hospital, as he discusses his upcoming Midyear sessions that focus on the role of pharmacists in the care of patients in cardiac arrest.   The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

325. Driving Innovations in EHRs - Pharmacy Product Management feat. Dr. Andrew McLaughlin Intended Audience: Everyone

Pharmacists providing rapid sequence intubation (RSI) care are faced with evolving standards of care in special patient populations. This episode features RSI pharmacology in special patient populations, including myasthenia gravis, pregnancy and obesity. CE for this episode expires on October 18, 2027.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this podcast, Dr. Dusty Linn discusses the AJHP Clinical Consultation "Strategies to prevent awareness with paralysis following administration of neuromuscular blocking agents” with host and AJHP Editor in Chief Dr. Daniel Cobaugh. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Collaborative practice agreements (CPAs) are formal agreements between pharmacists and other healthcare providers that allow pharmacists to perform specific tasks independently at the top of their license. CPAs are a powerful tool widely used in the outpatient setting but not used as frequently in the inpatient setting. This episode discusses the considerations for developing and implementing a successful inpatient CPA and the benefits to patient care quality, safety, and efficiency. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

ASHP's senior education director Cindy Von Heeringen is joined by Lisa Janssen Carlson, IDS manager, and Craig Michael, data science pharmacist, both from the University of California, San Francisco as they discuss their upcoming Midyear session that focuses on incorporating AI in current pharmacy practice settings to enhance or streamline workflows.   The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Members of the Council on Therapeutics unpack two ASHP policies adopted in the 2025 House of Delegates— one addressing the FDA's proposal to change drug naming conventions, and the other requiring height and weight on certain medication orders. They share why these policies matter, the challenges encountered during the policy process, and the improvements they hope to see in patient care as a result. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.